Arkema OTC Stock Valuation

ARKAF -  USA Stock  

USD 126.40  7.60  5.67%

What is the value of Arkema today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Arkema, is its stock price multiplied by the total number of shares outstanding, calculating Arkema's enterprise value requires a different approach. It uses Arkema's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Arkema shows a prevailing Real Value of $125.73 per share. The current price of the firm is $126.4. At this time, the firm appears to be fairly valued. Our model approximates the value of Arkema from analyzing the firm fundamentals such as Return On Equity of 6.81 %, current valuation of 11.03 B, and Profit Margin of 4.71 % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor purchasing undervalued instruments and exiting overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

Arkema Valuation 

 
Refresh
Arkema Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Arkema's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Fairly Valued
Today
126.40
21st of October 2021
Share
Please note that Arkema's price fluctuation is very steady at this time. Calculation of the real value of Arkema is based on 3 months time horizon. Increasing Arkema's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Arkema is useful when determining the fair value of the Arkema otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Arkema. Since Arkema is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Arkema OTC Stock. However, Arkema's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
124.83
Downside
125.73
Real Value
126.63
Upside
Estimating the potential upside or downside of Arkema helps investors to forecast how Arkema otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Arkema more accurately as focusing exclusively on Arkema's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
124.02126.64129.26
Details
Hype
Prediction
LowEstimated ValueHigh
125.50126.40127.30
Details
Potential
Annual Dividend
LowIncome Per ShareHigh
1.731.751.78
Details

Arkema Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Arkema's current stock value. Our valuation model uses many indicators to compare Arkema value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Arkema competition to find correlations between indicators driving Arkema's intrinsic value. More Info.
Arkema is number one stock in last dividend paid category among related companies. It is number one stock in beta category among related companies totaling about  0.43  of Beta per Last Dividend Paid. The ratio of Last Dividend Paid to Beta for Arkema is roughly  2.33 

About Arkema Valuation

The equity valuation mechanism determines the current worth of Arkema on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Arkema. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Arkema based exclusively on its fundamental and basic technical indicators. By analyzing Arkema's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Arkema's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Arkema. We calculate exposure to Arkema's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Arkema's related companies.
Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. It operates in three segments Adhesive Solutions, Advanced Materials, and Coating Solutions. Its products include acrylics, coating resins, electroactive polymers, fluorochemicals, fluoropolymers, functional polyolefins, hydrazine hydrate, hydrogen peroxide, molecular sieves, organic peroxide, oxygenated solvents, polyetherketoneketone, plastic additives, polymethyl methacrylate resins and sheets, rheology additives, solutions for glass coating, specialty adhesives, specialty polyamides, surfactants and additives, technical fluids, and thiochemicals. The company also offers UV, LED, EB curable resins, and specialty acrylates. It offers adhesive solutions used in building activities for businesses and individuals, including sealants, tile and flooring adhesives, and waterproofing systems, as well as in automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets advanced materials used in the automotive and transportation, oil and gas, renewable energies, consumer goods, electronics, construction, coatings, animal nutrition, and water treatment coating solutions for decorative paints, industrial coatings, adhesives, paper, superabsorbents, water treatment, oil and gas extraction, 3D printing, and electronics applications and industrial intermediate chemicals for the construction, production of refrigeration and air conditioning, automotive, and water treatment applications. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France.

Arkema Dividends Analysis For Valuation

There are various types of dividends Arkema can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Arkema shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Arkema directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Arkema pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Arkema by the value of the dividends paid out.

Arkema Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Arkema does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio1.78
Earnings Quarterly Growth59.00%
Revenue Growth6.60%
Payout Ratio49.00%
Enterprise Value To Ebitda9.65
Earnings Growth52.00%
Enterprise Value To Revenue1.38
Please continue to Trending Equities. Note that the Arkema information on this page should be used as a complementary analysis to other Arkema's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Arkema OTC Stock analysis

When running Arkema price analysis, check to measure Arkema's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arkema is operating at the current time. Most of Arkema's value examination focuses on studying past and present price action to predict the probability of Arkema's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arkema's price. Additionally, you may evaluate how the addition of Arkema to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
The market value of Arkema is measured differently than its book value, which is the value of Arkema that is recorded on the company's balance sheet. Investors also form their own opinion of Arkema's value that differs from its market value or its book value, called intrinsic value, which is Arkema's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arkema's market value can be influenced by many factors that don't directly affect Arkema underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arkema's value and its price as these two are different measures arrived at by different means. Investors typically determine Arkema value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arkema's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.